New Treatments in Development User Group
This group is to discuss new treatments in development to have a better understanding of the future of recovery.
Founded by ILADVOCATE on September 22, 2009
39 members
39 members
Search this Group:
http://www.nytimes.com/2010/09/14/health/research/14bowel.html?_r=1&ref=todayspaper
"Drug for Irritable Bowel Achiev...
3
Trans cranial magnetic stimulation which works in a similar manner to ECT but appears to have a safer long term side ...
4
This information explains how a new class of adjunct antipsychotics is being researched from understanding the effect...
ILADVOCATEAug 11, 2010
1
''GlaxoSmithKline (GSK) has developed a way of printing active pharmaceutical ingredients onto tablets. Currently the...
ILADVOCATEAug 11, 2010
M4Y0UAug 11, 2010
2
http://www.nytimes.com/2010/08/10/health/10depress.html
"Anesthetic Said to Aid Depression"
"A new study sugges...
"About 40-50% of people taking the current antidepressants, or the SSRIs, stop treatment shortly after starting. Thi...
paranoid_cataclysmMay 22, 2010
1
This is one of the first treatments to be able to treat Fragile X syndrome, a common cause of developmental disabilit...
M4Y0UMay 09, 2010
ILADVOCATEApr 25, 2010
2
Prozac and other well established antidepressants could be the latest weapon in the fight against cancer, claim scien...
People Might Have Questions on What are the Various Levels of Clinical Trials For Any Medications and How They Work. ...
3
This information is clinically accurate and there are still ongoing studies. It is also in clinical study for tardive...
Sorry for not posting this sooner. Anyone is free to join and post. The discussions are for informational purposes on...
4
In order to develop, a tumor activates the proliferation of blood vessels. Angiogenesis is the formation of new blood...
3
Brain tumors, unfortunately, do not respond to any known treatment. The blood-brain barrier performs a neuroprotectiv...
4
This is a new antipsychotic Saphris that was FDA approved recently.
http://www.fda.gov/NewsEvents/Newsroom/PressAnn...
ILADVOCATEOct 10, 2009
paranoid_cataclysmOct 10, 2009
2
The NMDA receptor modulates are a class of antipsychotic in Phase II FDA study. Glycine is one of these compounds. I ...
Just keeping people updated. Google the medication website for more information. Like Saphris, Fanapt is a new option...
3
This might provide some information on FDA approved treatments used off label for bipolar and depression.
Lovaza for...
Recent Activity
Most Popular Trackers
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.
This site complies with the HONcode standard for trustworthy health information: verify here.
Copyright © 1993-2012 Med Help. All rights reserved.
